Back
Grace Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
64
GRCE
Grace Therapeutics
Last Price:
$3.36
Seasonality Move:
-4.61%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GRCE is experiencing slight selling pressure.
Grace Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.23 | Buy |
20-day SMA: | 3.09 | Buy |
50-day SMA: | 2.96 | Buy |
200-day SMA: | 3.09 | Buy |
8-day EMA: | 2.84 | Buy |
20-day EMA: | 1.79 | Buy |
50-day EMA: | 0.89 | Buy |
200-day EMA: | 0.25 | Buy |
Grace Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.91 | Buy |
Relative Strength Index (14 RSI): | 62.02 | Buy |
Chaikin Money Flow: | -5084 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.89 - 3.21) | Buy |
Bollinger Bands (100): | (2.33 - 3.09) | Buy |
Grace Therapeutics Technical Analysis
Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Grace Therapeutics Stock
Is Grace Therapeutics Stock a Buy?
-
Grace Therapeutics share price is 3.35 while GRCE 8-day simple moving average is 3.23, which is a Buy signal.
-
The stock price of GRCE is 3.35 while Grace Therapeutics 20-day SMA is 3.09, which makes it a Buy.
-
Grace Therapeutics 50-day simple moving average is 2.96 while GRCE share price is 3.35, making it a Buy technically.
-
GRCE stock price is 3.35 and Grace Therapeutics 200-day simple moving average is 3.09, creating a Buy signal.
GRCE Technical Analysis vs Fundamental Analysis
Buy
64
Grace Therapeutics (GRCE)
is a Buy
Is Grace Therapeutics a Buy or a Sell?
-
Grace Therapeutics stock is rated a BuyThe current Grace Therapeutics [GRCE] share price is $3.35. The Score for GRCE is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
Grace Therapeutics Stock Info
Market Cap:
46.3M
Price in USD:
3.35
Share Volume:
30.1K
Grace Therapeutics 52-Week Range
52-Week High:
4.97
52-Week Low:
1.75
Buy
64
Grace Therapeutics (GRCE)
is a Buy
Grace Therapeutics Share Price Forecast
-
What is the Grace Therapeutics stock price today?The Grace Therapeutics stock price is 3.35 USD today.
-
Will GRCE stock go up or go down?Grace Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Grace Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Grace Therapeutics is not overvalued.
Is Grace Therapeutics Stock a Buy?
-
Grace Therapeutics share price is 3.35 while GRCE 8-day exponential moving average is 2.84, which is a Buy signal.
-
The stock price of GRCE is 3.35 while Grace Therapeutics 20-day EMA is 1.79, which makes it a Buy.
-
Grace Therapeutics 50-day exponential moving average is 0.89 while GRCE share price is 3.35, making it a Buy technically.
-
GRCE stock price is 3.35 and Grace Therapeutics 200-day simple moving average is 0.25, creating a Buy signal.
Fundamental Analysis of Grace Therapeutics
Is Grace Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.06 per share, an increase this year of $0.23 per share, and an increase next year of $0.66 per share.
Technical Analysis of Grace Therapeutics
Should I short Grace Therapeutics stock?
-
GRCE Moving Average Covergence Divergence (MACD) indicator is 0.91, suggesting Grace Therapeutics is a Buy
-
Grace Therapeutics Relative Strength Index (RSI) is 62.02, which suggest Grace Therapeutics is overbought
-
The Bollinger Bands (25) for Grace Therapeutics is (2.89 - 3.21), which suggest Grace Therapeutics is a Buy
-
The Bollinger Bands (100) for Grace Therapeutics is (2.33 - 3.09), which suggest Grace Therapeutics is a Buy
* Grace Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.